Skip to content
What Is Candida Vaginitis
Candida vaginitis, a common fungal infection caused by Candida albicans. It’s a problem that around 75% of women encounter at least once in their lives, with nearly half experiencing recurring episodes. While standard antifungal medications are effective, their long-term use can harm the healthy tissues of the vagina. This, in turn, leads to imbalances in vaginal microbiota, acid-base imbalance, and recurrent infections.
Lactobacillus-based treatments are considered safe due to their ability to produce hydrogen peroxide, lactic acid, and bacteriocins. However, the Candida fungus has developed a higher tolerance to these substances, rendering the treatment ineffective.
To address this challenge, Chinese scientists have developed a breakthrough solution – a responsive hyaluronic acid hydrogel that targets Candida albicans, restores vaginal microbiota, and prevents infection recurrence. This innovative hydrogel contains hydroxyl radical-producing nanozymes and lactic acid- and hydrogen peroxide-producing Lactobacillus to combat the infection.
Mode of Action of the Hydrogel
Upon application in the vaginal area, the hyaluronic acid hydrogel undergoes enzymatic degradation by Candida albicans-produced hyaluronidase. This process triggers the localized release of nanozymes and Lactobacillus.
Once released, Lactobacillus synthesizes lactic acid to restore the vaginal microenvironment and maintain an optimal acidic pH level. The abundant hydrogen peroxide produced by Lactobacillus is further catalyzed by nanozymes, generating highly toxic hydroxyl radicals. These radicals effectively target and eliminate Candida albicans.
The combined treatment of nanozymes and Lactobacillus has shown impressive results, with a remarkable 70% reduction in the viability of the yeast infection.
The Therapeutic and Preventive Action of the Hydrogel for Candida Vaginitis
Experimental studies were conducted by researchers using clinically isolated Candida albicans, providing additional confirmation of the potent antifungal effects of the combined treatment. These findings demonstrated a significant detrimental impact on the viability of the fungus and its ability to form colonies.
In vivo experiments utilizing a mouse model of the infection revealed that the combined treatment not only effectively eradicates the causative agent, but also promotes the restoration of a healthy vaginal microbiota. It enhances the diversity of the microbial community while minimizing any substantial damage to the vaginal mucosa. As a result, the risk of recurrence is significantly reduced.
Moreover, the hydrogel formulation exhibits remarkable stability of its antifungal activity even when exposed to oxygen under vacuumed conditions. This ensures the integrity of the functional synergy between the nanozymes and Lactobacillus combination during storage in a vacuumed environment, thereby safeguarding its therapeutic effectiveness.
